Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

NCT07416188 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

40

Enrollment

NIH

Sponsor class

Conditions

Recurrent Glioblastoma
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Relapsed Cancer
Recurrent Tumor
Glioblastoma Multiforme
Recurring Glioblastoma
Brain and Central Nervous System Tumors
Glioma
Glioblastomas
Grade IV Astrocytoma
GBM
Recurrent Glioma (Glioblastoma Multiforme)
High Grade Glioma
Glioma, Malignant
Brain Cancer

Interventions

DRUG: LMP744
PROCEDURE: Conventional Surgery or Biopsy

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)